Highest cash
paymentsThese cash-rich companies have proven their ability to accumulate substantial liquidity, positioning themselves with a strong financial advantage.
| name | Price | $ Change | % Change | Market Cap | Volume | Avg. Volume | arrow_downwardCash on Hand | Technicals | Dividend Y | ROI 1Y | Score language | Last 7 Days | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 CNMDCONMED | $62.14 | -$0.16 | arrow_drop_down0.25% | $1.92B | 375.73K | 62.31 | $28.86M | Neutralremove | 1.28% | -32.22% | AI Analysis | |||||
OFIXOrthofix Medical | $15.88 | $0.09 | arrow_drop_up0.57% | $605.45M | 131.02K | 15.85 | $28.86M | Neutralremove | - | 45.55% | AI Analysis | |||||
GENCGencor Industries | $19.59 | -$0.73 | arrow_drop_down3.55% | $287.63M | 25.78K | 20.04 | $28.78M | Neutralremove | - | 36.55% | AI Analysis | |||||
LARKLandmark Bancorp Inc-Manhattan KS | $20.17 | $20.17 | 0.00% | $112.52M | 195.00 | 20.35 | $28.77M | Neutralremove | 4.11% | 27.61% | AI Analysis | |||||
ATSGAir Transport Services Group | $16.66 | $0.49 | arrow_drop_up3.02% | $1.08B | 590.57K | 16.55 | $28.71M | Neutralremove | - | -12.63% | AI Analysis | |||||
APRE APREAprea Therapeutics | $4.08 | $0.24 | arrow_drop_up6.15% | $22.05M | 7.22K | 4.08 | $28.69M | Neutralremove | - | 3.81% | AI Analysis | |||||
MAXMediaAlpha | $19.44 | $0.13 | arrow_drop_up0.67% | $1.28B | 330.34K | 19.51 | $28.65M | Neutralremove | - | 102.50% | AI Analysis | |||||
CRMDCorMedix | $13.04 | $0.61 | arrow_drop_up4.89% | $773.13M | 2.31M | 13.05 | $28.54M | Neutralremove | - | 327.54% | AI Analysis | |||||
CGTXCognition Therapeutics | $0.56 | -$0.01 | arrow_drop_down3.20% | $23.05M | 317.16K | 0.58 | $28.53M | Neutralremove | - | -55.86% | AI Analysis | |||||
TSQTownsquare Media | $10.01 | -$0.26 | arrow_drop_down2.52% | $149.70M | 39.35K | 10.12 | $28.51M | Neutralremove | 7.68% | 20.31% | AI Analysis | |||||
GBIOGeneration Bio Co | $2.14 | -$0.03 | arrow_drop_down1.38% | $146.79M | 79.18K | 2.17 | $28.49M | Neutralremove | - | 128.67% | AI Analysis | |||||
MLABMesa Laboratories | $113.04 | -$3.38 | arrow_drop_down2.90% | $646.36M | 33.02K | 114.21 | $28.47M | Buykeyboard_arrow_up | 0.53% | 13.04% | AI Analysis | |||||
JILLJ. Jill | $24.31 | -$0.20 | arrow_drop_down0.83% | $368.21M | 68.80K | 24.32 | $28.46M | Neutralremove | 1.15% | -16.59% | AI Analysis | |||||
ALTOAlto Ingredients | $1.71 | -$0.01 | arrow_drop_down0.87% | $130.79M | 330.83K | 1.71 | $28.41M | Neutralremove | - | -54.52% | AI Analysis | |||||
NSPRInspireMD | $2.45 | -$0.01 | arrow_drop_down0.40% | $64.39M | 11.54K | 2.47 | $28.38M | Neutralremove | - | -22.71% | AI Analysis | |||||
METCBRamaco Resources, Inc. - Class B Common Stock | $10.21 | -$0.12 | arrow_drop_down1.16% | $524.64M | 3.70K | 10.26 | $28.37M | Neutralremove | 8.70% | -16.03% | AI Analysis | |||||
METC METCLMETCL | $25.69 | -$0.10 | arrow_drop_down0.42% | _ | 1.41K | 25.69 | $28.37M | Neutralremove | - | 1.38% | AI Analysis | |||||
METCRamaco Resources | $10.21 | -$0.14 | arrow_drop_down1.35% | $522.61M | 264.73K | 10.26 | $28.37M | Neutralremove | 5.31% | -14.12% | AI Analysis | |||||
DGIIDigi International | $29.86 | -$0.10 | arrow_drop_down0.33% | $1.11B | 212.49K | 30.27 | $28.33M | Neutralremove | - | 18.02% | AI Analysis | |||||
LSTALisata Therapeutics | $2.90 | $0.01 | arrow_drop_up0.63% | $24.15M | 9.94K | 2.94 | $28.29M | Neutralremove | - | 42.85% | AI Analysis |
Showing 3161-3180 of 4976
Results per page:
About Highest cash
Discover the stocks of companies with the most cash on hand, a key indicator of their financial strength and liquidity. Cash reserves play a vital role in a company's ability to fund operations, invest in growth opportunities, and navigate economic uncertainties without relying on external financing.
Investors seek companies with substantial cash reserves as it indicates stability and resilience in times of market volatility. High cash on hand stocks are often favored by conservative investors looking for secure investment options with lower risk.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools